Myeloperoxidase: A Therapeutic Target for Preventing Insulin Resistance and the Metabolic Sequelae of Obesity?

Diabetes - United States
doi 10.2337/db14-1273
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

AMPD1: A Novel Therapeutic Target for Reversing Insulin Resistance

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2014English

Brown Adipose Tissue Activity as a Target for the Treatment of Obesity/Insulin Resistance

Frontiers in Physiology
Physiology
2015English

GLUT 12 ‐ a Promising New Target for the Treatment of Insulin Resistance in Obesity and Type‐2 Diabetes

Acta Physiologica
Physiology
2019English

Irisin: As a Therapeutic Target for Metabolic Disorders

Journal of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2018English

Obesity and the Insulin Resistance Syndrome

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2005English

Obesity, Hypertension, and Insulin Resistance

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2002English

Obesity, Adipocytes and Insulin Resistance - Friends for Life?

Acta Physiologica
Physiology
2019English

Myeloperoxidase: A Target for New Drug Development?

British Journal of Pharmacology
Pharmacology
2007English

Obesity/Insulin Resistance Is Associated With Endothelial Dysfunction. Implications for the Syndrome of Insulin Resistance.

Journal of Clinical Investigation
Medicine
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy